Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TYCHE INDUSTRIES vs SHUKRA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TYCHE INDUSTRIES SHUKRA PHARMA TYCHE INDUSTRIES/
SHUKRA PHARMA
 
P/E (TTM) x 15.8 22.1 71.7% View Chart
P/BV x 1.9 16.2 11.9% View Chart
Dividend Yield % 0.9 0.5 170.0%  

Financials

 TYCHE INDUSTRIES   SHUKRA PHARMA
EQUITY SHARE DATA
    TYCHE INDUSTRIES
Mar-23
SHUKRA PHARMA
Mar-23
TYCHE INDUSTRIES/
SHUKRA PHARMA
5-Yr Chart
Click to enlarge
High Rs16389 183.5%   
Low Rs10511 944.2%   
Sales per share (Unadj.) Rs73.553.7 137.0%  
Earnings per share (Unadj.) Rs13.84.0 343.9%  
Cash flow per share (Unadj.) Rs15.65.7 273.1%  
Dividends per share (Unadj.) Rs2.000.50 400.0%  
Avg Dividend yield %1.51.0 149.1%  
Book value per share (Unadj.) Rs113.923.1 493.5%  
Shares outstanding (eoy) m10.2510.96 93.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.80.9 195.8%   
Avg P/E ratio x9.712.4 78.0%  
P/CF ratio (eoy) x8.68.8 98.3%  
Price / Book Value ratio x1.22.2 54.4%  
Dividend payout %14.512.4 116.3%   
Avg Mkt Cap Rs m1,372547 250.9%   
No. of employees `000NANA-   
Total wages/salary Rs m7044 157.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m754588 128.1%  
Other income Rs m4812 403.3%   
Total revenues Rs m802600 133.6%   
Gross profit Rs m16054 298.9%  
Depreciation Rs m1818 96.5%   
Interest Rs m03 0.4%   
Profit before tax Rs m19144 429.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m490 14,037.1%   
Profit after tax Rs m14244 321.6%  
Gross profit margin %21.39.1 233.3%  
Effective tax rate %25.70.8 3,248.5%   
Net profit margin %18.87.5 251.0%  
BALANCE SHEET DATA
Current assets Rs m1,219531 229.7%   
Current liabilities Rs m210425 49.3%   
Net working cap to sales %133.918.0 745.6%  
Current ratio x5.81.2 465.5%  
Inventory Days Days130-  
Debtors Days Days1,0691,873 57.1%  
Net fixed assets Rs m192219 87.7%   
Share capital Rs m10239 261.8%   
"Free" reserves Rs m1,065214 498.1%   
Net worth Rs m1,168253 461.5%   
Long term debt Rs m038 0.0%   
Total assets Rs m1,411750 188.2%  
Interest coverage x19,085.016.8 113,548.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.50.8 68.1%   
Return on assets %10.06.3 160.6%  
Return on equity %12.117.4 69.7%  
Return on capital %16.316.2 100.6%  
Exports to sales %57.90-   
Imports to sales %19.90-   
Exports (fob) Rs m437NA-   
Imports (cif) Rs m150NA-   
Fx inflow Rs m4370-   
Fx outflow Rs m1610-   
Net fx Rs m2750-   
CASH FLOW
From Operations Rs m6832 215.2%  
From Investments Rs m19-44 -43.9%  
From Financial Activity Rs m-1549 -31.1%  
Net Cashflow Rs m7237 196.2%  

Share Holding

Indian Promoters % 62.0 51.0 121.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.1 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 38.0 49.0 77.5%  
Shareholders   7,867 12,974 60.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TYCHE INDUSTRIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on TYCHE INDUSTRIES vs RELISH PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

TYCHE INDUSTRIES vs RELISH PHARMA Share Price Performance

Period TYCHE INDUSTRIES RELISH PHARMA S&P BSE IT
1-Day 1.27% 1.97% 0.10%
1-Month 20.94% 9.88% -3.37%
1-Year 21.95% 327.40% 27.91%
3-Year CAGR -2.70% 161.08% 9.37%
5-Year CAGR 26.63% 96.81% 16.49%

* Compound Annual Growth Rate

Here are more details on the TYCHE INDUSTRIES share price and the RELISH PHARMA share price.

Moving on to shareholding structures...

The promoters of TYCHE INDUSTRIES hold a 62.0% stake in the company. In case of RELISH PHARMA the stake stands at 51.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of TYCHE INDUSTRIES and the shareholding pattern of RELISH PHARMA.

Finally, a word on dividends...

In the most recent financial year, TYCHE INDUSTRIES paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 14.5%.

RELISH PHARMA paid Rs 0.5, and its dividend payout ratio stood at 12.4%.

You may visit here to review the dividend history of TYCHE INDUSTRIES, and the dividend history of RELISH PHARMA.

For a sector overview, read our software sector report.



Today's Market

Gift Nifty Up 63 Points | HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today Gift Nifty Up 63 Points | HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.